Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

Extraosseous calcification in kidney disease

Korey Bartolomeo, DO, Xin Yee Tan, MD and Richard Fatica, MD
Cleveland Clinic Journal of Medicine February 2022, 89 (2) 81-90; DOI: https://doi.org/10.3949/ccjm.89a.21073
Korey Bartolomeo
Department of Kidney Medicine, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Xin Yee Tan
Department of Kidney Medicine, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Fatica
Vice-chair, Department of Kidney Medicine, Glickman Urological & Kidney Institute, Cleveland Clinic; Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Find this author on Cleveland Clinic
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Calcium and phosphate metabolism in chronic kidney disease. Decreased glomerular filtration rate (GFR) leads to changes in serum calcium and phosphate, triggering release of parathyroid hormone (PTH) from the parathyroid glands and fibroblast growth factor 23 (FGF-23) from osteoblasts and osteocytes. These hormones have complex downstream effects on the kidney, gut, and bone, both from direct effects on the tissue and from indirect effects through modulation of enzyme activity in vitamin D conversion.

    aMinimally increased.

    25(OH) vitamin D = 25-hydroxycholecalciferol; 1,25(OH)2 vitamin D = 1,25-dihydroxycholecalciferol

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Calciphylaxis in a 51-year-old man with end-stage kidney disease.

    From reference 27.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Radiography shows calcified masses (arrows) in a 47-year-old woman with tumoral calcinosis.

    From reference 30.

Tables

  • Figures
    • View popup
    TABLE 1

    Common terms used to describe calcification

    Soft tissue calcification
    Dystrophic calcification: occurring in damaged or degenerated tissue in the setting of normal metabolic factors
    Metastatic calcification: occurring in otherwise normal tissue, secondary to deranged metabolic factors, as in hypercalcemia
    Calciphylaxis (calcific uremic arteriopathy): ischemic skin lesions characterized by calcium deposition and thrombosis in the dermis and subcutaneous adipose tissue, most commonly associated with advanced kidney disease
    Calcinosis cutis universalis: diffuse involvement of subcutaneous and fibrous structures, most commonly in association with autoimmune disorders
    Tumoral calcinosis: massive deposition of calcium-phosphorus crystals in periarticular areas
    Calcinosis circumscripta: localized or isolated calcification; term sometimes used if calciphylaxis involvement is limited to an extremity
    Vascular calcification
    Atherosclerotic (intimal) calcification: inflammatory vaso-occlusive calcification of intima as a result of endothelial dysfunction
    Monckeberg arterial calcification: medial calcification deposition in small and medium arteries without luminal narrowing
    Infantile calcification: extensive calcification of medium and large arteries due to ENPP1 gene mutation
    • View popup
    TABLE 2

    Risk factors associated with vascular calcification

    Traditional risk factors
    Hypertension
    Diabetes mellitus
    Old age
    Smoking
    Dyslipidemia
    Family history of premature coronary artery disease
    Male sex
    Increased levels of C-reactive protein or other
    inflammatory markers
    Kidney disease-related risk factors
    Longer hemodialysis duration
    Persistent hyperphosphatemia
    Increased calcium-phosphate product
    Calcium-containing phosphate binders
    Secondary hyperparathyroidism
    Adynamic bone disease
    Vitamin D deficiency and excessive vitamin D administration
    High dialysate calcium
    Hypomagnesemia
    Low fetuin-A
    Low albumin
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 89 (2)
Cleveland Clinic Journal of Medicine
Vol. 89, Issue 2
1 Feb 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Extraosseous calcification in kidney disease
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
Please verify that you are a real person.
Citation Tools
Extraosseous calcification in kidney disease
Korey Bartolomeo, Xin Yee Tan, Richard Fatica
Cleveland Clinic Journal of Medicine Feb 2022, 89 (2) 81-90; DOI: 10.3949/ccjm.89a.21073

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Extraosseous calcification in kidney disease
Korey Bartolomeo, Xin Yee Tan, Richard Fatica
Cleveland Clinic Journal of Medicine Feb 2022, 89 (2) 81-90; DOI: 10.3949/ccjm.89a.21073
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget

Jump to section

  • Article
    • ABSTRACT
    • NAMES AND PRESENTATIONS
    • REGULATION OF CALCIUM AND PHOSPHATE
    • CALCIUM-PHOSPHATE AXIS DERANGEMENTS
    • PRESENTATION AND DIAGNOSIS
    • MEDICAL THERAPY
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Extraosseous calcification in kidney disease
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • High-output heart failure from arteriovenous dialysis access: A structured approach to diagnosis and management
  • Direct oral anticoagulants: Challenging prescribing scenarios in everyday practice
  • IgA nephropathy: Update on pathogenesis and treatment
Show more Review

Similar Articles

Subjects

  • Drug Therapy
  • Imaging
  • Nephrology
  • Preventive Care

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire